Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
I'm PortAI, I can summarize articles.
Biogen Inc. (BIIB) shares rose 2.88% to $174.80, outperforming competitors on a strong trading day. The S&P 500 Index increased by 0.88% and the Dow Jones by 0.38%. Biogen's stock is 5.60% below its 52-week high of $185.17. Trading volume was significantly higher than the 50-day average. Competitors like Johnson & Johnson fell 0.93%, while Pfizer and AbbVie saw gains of 0.60% and 1.80%, respectively.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments